Thus, these results show the key role of Gal-3 in the early LV remodeling associated with IR injury and the beneficial effects of Gal-3 pharmacological inhibition on cardiac fibrosis and inflammation, the two key processes underlying the cardiac functional alterations which finally affect heart function, leading to HF. The gene discussed is LGALS3; the disease is hydrops fetalis.